Agkistrodon piscivorus antivenin

DB13894ApprovedProtein Based TherapiesAntivenins

Agkistrodon piscivorus antivenin is a mixture of antibodies used to treat venomous snake bites from the Crotalinae family (pit vipers). Agkistrodon piscivorus antivenin is derived and purified immunoglobulin fragments obtained from other domestic animals such as sheep previously immunized with Agkistrodon piscivorus (Cottonmouth or Water Moccasin snake).

Mechanism
Curator reviewed
Primary indication
CROFAB is a sheep-derived antivenin indicated for the management of adult and pediatric patients with North American crotalid envenomation.Curator reviewed · 1 structured indication
First approval
United States, 2000
Also known as
Agkistrodon piscivorus immune fab antivenin (ovine)
Brand names
  • Crofab

Resolves to

Clinical / RWD

What you can answer from here — as of April 02, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
4Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Structured indicationCondition, population, route and combination as fields, not prose
Sign in
1Marketed productAcross 1 country and 1 labeller
Sign in
10+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Agkistrodon piscivorus antivenin, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account